Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · HR 5791

BLOOD Centers Act

Refreshed 1 h ago

Introduced 2025-10-17Topic: health care · public health

Summary

AI-generated summary, report an error

This bill would require the federal health department, through the Food and Drug Administration, to create a faster approval process within 180 days for blood centers that want to add an apheresis collection device at a location not previously licensed for one. Under this process, the agency would have to approve the request within 30 days unless it shows a specific safety, purity, or potency concern at that location, or a systemic failure by the operator to meet standards at other locations. The faster process would apply only to operators that hold a license for at least one blood center and either have 3 or more FDA-registered licensed locations or are accredited and in good standing with an approved accreditation organization.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2025-10-17HouseReferred to the House Committee on Energy and Commerce.refer
2025-10-17Introduced in Houseintroduce
2025-10-17Introduced in Houseintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-10-06. Provisions and opinion polling arrive in a later release.